Frederick Racke

2.4k citations

44 papers · 1.7k indexed · h-index 20

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Platelet Disorders and Treatments
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 21
- Acute Myeloid Leukemia Research 11
- Platelet Disorders and Treatments 7
- Chronic Myeloid Leukemia Treatments 6
Genetics 12
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Chronic Lymphocytic Leukemia Research 4

Co-authors: Adam N. Goldfarb Lorrie L. Delehanty Kamaleldin E. Elagib Kristine Lewandowska Said A. Goueli Edward F. Nemeth Chi V. Dang Kathryn A. O’Donnell
Journals: Blood (14 papers)Journal of Biological Chemistry (4 papers)British Journal of Haematology (2 papers)The Journal of Physiology (2 papers)Molecular and Cellular Biology (2 papers)
Partner nations: United States Australia Germany

In The Last Decade

Frederick Racke

41 papers receiving 1.6k citations

Peers

Countries citing papers authored by Frederick Racke

Since Specialization

Citations

This map shows the geographic impact of Frederick Racke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Racke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Racke more than expected).

Fields of papers citing papers by Frederick Racke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick Racke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Racke. The network helps show where Frederick Racke may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frederick Racke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frederick Racke Line = papers co-authored together Frederick Racke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia Blood Cancer Journal ·Yonghong Li, Irene Matusz, Fei Yang, Nicola Long, Carmen H. Tong, Felicitas Lacbawan, Frederick Racke, Richard D. Press	2023	12
2	Heparin-Induced Thrombocytopenia Testing: ELISA Based Anti-Platelet Factor 4 Polyspecific and IgG-Specific Antibody Detection Assays Compared to the Unfractionated Heparin Serotonin Release Assay Blood ·Edward C.C. Wong, Mark Saunders, Caixia Bi, SHIRLEY A. FAYLE, Sadok BEN AMARA, William Wu, Mervyn A. Sahud, Frederick Racke, Jeffrey S. Dlott	2021	1
3	Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms PLoS ONE ·Wenjie Hu, Анна Герасимова, Marie‐Aline Charles, Hairong Li, Andrew Grupe, Hansook Kim Chong, Allan Acab, 鲍永玲, Renius Owen, Christopher Elzinga, Rebecca Chen, N Ajay, Tracey Freitas, Jennifer Graham, Mohammad Hossein Haghighi, Anindya Bhattacharya, Frederick Racke, Felicitas Lacbawan	2021	5
4	The rapid Bethesda assay is equivalent to the standard Bethesda assay for detection of factor IX inhibitors in patients with severe haemophilia B Haemophilia ·Mervyn A. Sahud, Giuseppe Michetti, Stanley J. Naides, S.D. Arutyunov, Edward C.C. Wong, Jeffrey S. Dlott, Frederick Racke	2020	0
5	R634W KIT Mutation in an Adult With Systemic Mastocytosis Laboratory Medicine ·John Astle, Michal G. Rose, Frederick Racke, Christopher A. Tormey, Alexa J. Siddon	2017	2
6	Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH results Molecular Cytogenetics ·Morteza Hemmat, Weina Chen, Arturo Anguiano, Fr. Čuta, Frederick Racke, Dan Jones, Yongbao Wang, Charles M. Strom, Nutakki Sowjanya, Fatih Z Boyar	2014	8
7	Assessment of Mutation Status in a Large Series of Patients with Cytopenias with Normal Karyotypes and without Increased Blasts Blood ·Rebeca Andújar, Yongbao Wang, Russell L. Maiese, Kevin J. Arvai, Qiulu Pan, В.И. ВЕРШИНИН, Е.А. Константинова, Steven L. Gersen, مریم عبدالرازقی, Frederick Racke, Dan Jones	2014	1
8	Inter-reader variability in follicular lymphoma grading: Conventional and digital reading Journal of Pathology Informatics ·Gerard Lozanski, Michael L. Pennell, Arwa Shana’ah, Weiqiang Zhao, Maysa Madihah, Frederick Racke, Eric D. Hsi, AW Pedersen, Claudio A. Mosse, Susanna Piculell, Sharon L. Swierczynski, Robert P. Hasserjian, Metin N. Gürcan	2013	23
9	Unique In Vitro and In Vivo Thrombopoietic Activities of Ingenol 3,20 Dibenzoate, A Ca++-Independent Protein Kinase C Isoform Agonist PLoS ONE ·Frederick Racke, Álvaro Lavega, Rolf F. Barth, Tianyao Huo, Weilian Yang, Nilendu Gupta, Michael Weldon, H M Korchak	2012	6
10	Therapy-related pro-B cell acute lymphoblastic leukemia: report of two patients with MLL amplification Cancer Genetics ·Frederick Racke, 曾晓渊, Alison Walker, Jeffrey A. Jones, Nyla A. Heerema	2012	9
11	Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease Leukemia ·Brenda R. Baldwin, Kimiko Arakawa, M Vanderghinst, F. C. S., MI Collector, Katharine A. Whartenby, Saul J. Sharkis, Frederick Racke, David L. Huso, Donald Small	2007	11
12	Telomere length shortening in Langerhans cell histiocytosis British Journal of Haematology ·Qiu Xinyi, Alan K. Meeker, Angelo M. De Marzo, Frederick Racke, Ronald Jaffe, Elizabeth A. Sugar, R.J. Arceci	2007	15
13	Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis Molecular and Cellular Biology ·Kathryn A. O’Donnell, Duonan Yu, Karen Zeller, Jung‐whan Kim, Frederick Racke, Andrei Thomas‐Tikhonenko, Chi V. Dang	2006	195
14	Defective Human MutY Phosphorylation Exists in Colorectal Cancer Cell Lines with Wild-type MutY Alleles Journal of Biological Chemistry ·Antony R. Parker, Robert N. O’Meally, Fikrettin Şahιn, Gloria H. Su, Frederick Racke, William G. Nelson, Theodore L. DeWeese, James R. Eshleman	2003	38
15	Stromal Inhibition of Megakaryocytic Differentiation Correlates with Blockade of Signaling by Protein Kinase C-ε and ERK/MAPK Journal of Biological Chemistry ·Adam N. Goldfarb, Olga Vaskivska, Dongyan Wang, Frederick Racke, Isa M. Hussaini	2001	20
16	A Potential Role for Protein Kinase C-ε in Regulating Megakaryocytic Lineage Commitment Journal of Biological Chemistry ·Frederick Racke, Dongyan Wang, 淳子岡田, Joshua B. Kelley, Jane E. Visvader, Jae‐Won Soh, Adam N. Goldfarb	2001	42
17	CD1d on Myeloid Dendritic Cells Stimulates Cytokine Secretion from and Cytolytic Activity of Vα24JαQ T Cells: A Feedback Mechanism for Immune Regulation The Journal of Immunology ·Otto O. Yang, Frederick Racke, Phuong Nguyen, 辛迪嘉, Michael E. Severino, Heidi F. Horton, Michael C. Byrne, Jack L. Strominger, S. Brian Wilson	2000	59
18	Pseudo-Spikes Are Common in Histologically Benign Lymphoid Tissues Journal of Molecular Diagnostics ·Soo Chin Lee, Karin D. Berg, Frederick Racke, Constance A. Griffin, James R. Eshleman	2000	47
19	Sustained Activation of the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway Is Required for Megakaryocytic Differentiation of K562 Cells Journal of Biological Chemistry ·Frederick Racke, Kristine Lewandowska, Said A. Goueli, Adam N. Goldfarb	1997	162
20	Functional expression of the parathyroid cell calcium receptor in Xenopus oocytes FEBS Letters ·Frederick Racke, Lance G. Hammerland, George Dubyak, Edward F. Nemeth	1993	25

About Frederick Racke

Frederick Racke is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Immunology and Nephrology, having authored 44 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (8 papers), Platelet Disorders and Treatments (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Hematology (708 citations), Genetics (310 citations), Immunology (388 citations), Cancer Research (171 citations) and Molecular Biology (747 citations). Frederick Racke has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Adam N. Goldfarb, Lorrie L. Delehanty, Kamaleldin E. Elagib, Kristine Lewandowska, Said A. Goueli, Edward F. Nemeth, Chi V. Dang, Kathryn A. O’Donnell, Jung‐whan Kim and Duonan Yu. Their work appears in journals such as Blood, Journal of Biological Chemistry, British Journal of Haematology, The Journal of Physiology and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact